ES2056981T3 - Composiciones dotadas de una capacidad de penetracion mejorada. - Google Patents

Composiciones dotadas de una capacidad de penetracion mejorada.

Info

Publication number
ES2056981T3
ES2056981T3 ES89104017T ES89104017T ES2056981T3 ES 2056981 T3 ES2056981 T3 ES 2056981T3 ES 89104017 T ES89104017 T ES 89104017T ES 89104017 T ES89104017 T ES 89104017T ES 2056981 T3 ES2056981 T3 ES 2056981T3
Authority
ES
Spain
Prior art keywords
compositions
layer
penetration capacity
active medicament
improved penetration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89104017T
Other languages
English (en)
Inventor
Majid Mahjour
Bernadette Mauser
Zahra A Rashidbaigi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32512850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2056981(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Priority claimed from ZA91624A external-priority patent/ZA91624B/xx
Application granted granted Critical
Publication of ES2056981T3 publication Critical patent/ES2056981T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physical Water Treatments (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Laminated Bodies (AREA)

Abstract

LA PENETRACION DE VARIAS DROGAS A TRAVES DE MEMBRANAS VIVAS SE MEJORA MEDIANTE SU USO EN COMPOSICIONES TRANSDERMICAS CONTENIENDO CIERTOS SISTEMAS DE PENETRACION ELEVADA.
ES89104017T 1988-03-08 1989-03-07 Composiciones dotadas de una capacidad de penetracion mejorada. Expired - Lifetime ES2056981T3 (es)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US16532288A 1988-03-08 1988-03-08
ZA91624A ZA91624B (en) 1991-01-28 1991-01-28 Delivery device for compositions with enhanced penetration and process for preparing same
NZ236921A NZ236921A (en) 1988-03-08 1991-01-28 Laminate for transmembranal administration of a drug
AU70061/91A AU634015B2 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
IE30591A IE64308B1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
CA002035143A CA2035143A1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
FI910455A FI910455A (fi) 1988-03-08 1991-01-30 Komposition med foerbaettrad penetration.
KR1019910001750A KR100191456B1 (ko) 1988-03-08 1991-02-01 침투력이 향상된 조성물
NO91910403A NO910403L (no) 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat.
JP3038921A JPH04338325A (ja) 1988-03-08 1991-02-12 増強された浸透性を有する組成物
PT96779A PT96779B (pt) 1988-03-08 1991-02-15 Laminado composito de duas camadas
EP91102354A EP0499662B1 (en) 1988-03-08 1991-02-19 Compositions with enhanced penetration

Publications (1)

Publication Number Publication Date
ES2056981T3 true ES2056981T3 (es) 1994-10-16

Family

ID=32512850

Family Applications (2)

Application Number Title Priority Date Filing Date
ES89104017T Expired - Lifetime ES2056981T3 (es) 1988-03-08 1989-03-07 Composiciones dotadas de una capacidad de penetracion mejorada.
ES91102354T Expired - Lifetime ES2064780T3 (es) 1988-03-08 1991-02-19 Composiciones con penetracion mejorada.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES91102354T Expired - Lifetime ES2064780T3 (es) 1988-03-08 1991-02-19 Composiciones con penetracion mejorada.

Country Status (16)

Country Link
EP (2) EP0332147B1 (es)
JP (2) JP2939264B2 (es)
KR (1) KR100191456B1 (es)
AT (2) ATE90571T1 (es)
AU (2) AU611771B2 (es)
CA (1) CA2035143A1 (es)
DE (2) DE68907081T2 (es)
DK (2) DK175621B1 (es)
ES (2) ES2056981T3 (es)
FI (1) FI910455A (es)
GR (1) GR3014988T3 (es)
IE (2) IE62871B1 (es)
NO (1) NO910403L (es)
NZ (2) NZ228094A (es)
PH (1) PH26548A (es)
PT (1) PT96779B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
WO1991015176A1 (en) * 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
DE4334919A1 (de) * 1993-10-13 1995-04-20 Liedtke Pharmed Gmbh Grenzwertig wirksame Arzneiformen mit Betablockern
KR100192149B1 (ko) * 1994-10-24 1999-06-15 이시노 요시푸사 경피 투여형 제제
DE19533089C1 (de) * 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
US6916486B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US6998138B2 (en) 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6916487B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US6646379B1 (en) 1998-12-25 2003-11-11 Matsushita Electric Industrial Co., Ltd. Metal vapor discharge lamp having cermet lead-in with improved luminous efficiency and flux rise time
AU770365B2 (en) * 1998-12-11 2004-02-19 Bakulesh Mafatlal Khamar The process for manufacturing formulation of topical beta blockers with improved efficacy
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
BRPI0617294B8 (pt) 2005-10-12 2021-05-25 Besins Healthcare Lu Sarl composição farmacêutica em gel hidroalcóolico e uso de testosterona
JP5052558B2 (ja) * 2009-04-03 2012-10-17 ロート製薬株式会社 ゲル軟膏

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153294B (it) * 1981-10-23 1987-01-14 Oreal Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
EP0196769B1 (en) * 1985-02-25 1992-07-08 Rutgers, The State University of New Jersey A novel transdermal pharmaceutical absorption dosage unit
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration

Also Published As

Publication number Publication date
IE910305A1 (en) 1992-07-29
JPH01272519A (ja) 1989-10-31
NO910403L (no) 1992-08-03
EP0332147A2 (en) 1989-09-13
DK109689A (da) 1989-09-09
DE69105480D1 (de) 1995-01-12
DE68907081T2 (de) 1993-10-21
GR3014988T3 (en) 1995-05-31
PT96779A (pt) 1992-08-31
FI910455A (fi) 1992-07-31
NZ228094A (en) 1991-09-25
NZ236921A (en) 1993-08-26
FI910455A0 (fi) 1991-01-30
AU634015B2 (en) 1993-02-11
JPH04338325A (ja) 1992-11-25
DK109689D0 (da) 1989-03-07
CA2035143A1 (en) 1992-07-30
EP0332147B1 (en) 1993-06-16
ES2064780T3 (es) 1995-02-01
PT96779B (pt) 1998-09-30
DK0499662T3 (da) 1995-05-15
JP2939264B2 (ja) 1999-08-25
ATE114481T1 (de) 1994-12-15
IE64308B1 (en) 1995-07-26
DK175621B1 (da) 2004-12-27
AU611771B2 (en) 1991-06-20
DE69105480T2 (de) 1995-04-06
PH26548A (en) 1992-08-19
EP0499662A1 (en) 1992-08-26
AU3025889A (en) 1989-09-14
KR100191456B1 (ko) 1999-06-15
DE68907081D1 (de) 1993-07-22
KR920016085A (ko) 1992-09-24
NO910403D0 (no) 1991-02-01
ATE90571T1 (de) 1993-07-15
EP0499662B1 (en) 1994-11-30
IE890390L (en) 1989-09-08
IE62871B1 (en) 1995-03-08
EP0332147A3 (en) 1990-09-19
AU7006191A (en) 1992-08-20

Similar Documents

Publication Publication Date Title
ES2056981T3 (es) Composiciones dotadas de una capacidad de penetracion mejorada.
AU1948095A (en) Timber structural component with timber layers
DE68921473D1 (de) Geschichtete zusammensetzung für die transdermale verabreichung von fentanyl.
KR900007595A (ko) 개선된 라미네이트 복합체 및 그 제조 방법
GB2234024B (en) Carbon composite laminated structures
DE3677131D1 (de) Laminate und aus diesen hergestellte formen.
DE3582169D1 (de) Polyepoxyd und halogeniertes dihydriertes phenol enthaltende vernetzbare zusammensetzungen und impraegnierte substrate und so hergestellte laminate.
FR2754740B1 (fr) Composite actif a structure feuilletee comprenant un agent actif sous forme de granules
EP0266775A3 (en) Laminates
BR8904152A (pt) Composicao,composicao curavel,verniz de laminacao,substrato,laminado e composicao de agente de cura
TW427943B (en) Deoxidizing multilayered body and its manufacturing method
EP1106221A3 (de) Holzschiene für ein Fahrgeschäft sowie Verfahren zur Herstellung und zum Montieren einer solchen Holzschiene
CA2120458A1 (en) Wood Flooring System
DE3578835D1 (de) Haertbare gummizusammensetzung.
EP0481810A3 (en) Rubber composition for laminated vibrationproofing structure
DK609787D0 (da) Let konstruktionselement
IE45741L (en) Antihelmintic combination
IT1222735B (it) Composizioni farmaceutiche laminate transdermali ad effetto prolungato e procedimento per la loro preparazione
JPS6452942A (en) Vibration-damping composite board
DE3860778D1 (de) Flammhemmende harzzusammensetzung und damit hergestelltes laminat.
IT8820921A0 (it) Struttura meccanica polivalente, in particolare per salvataggio e sopravvivenza.
IT8322388V0 (it) Quadro elettrico per comando di macchinari in genere, ed in particolare per comando di gru a torre o simili.
SE8902419L (sv) Anordning foer att aastadkomma en grundkonstruktion
ES1008159Y (es) Mesa de billar perfeccionada.
IT8802915A0 (it) Coperta per letto composita ad elevato potere isolante, traspirante ed assorbente.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 332147

Country of ref document: ES